Header Logo

Connection

DANIEL MEDINA to Administration, Oral

Back to Details
This is a "connection" page, showing publications DANIEL MEDINA has written about Administration, Oral.
DANIEL MEDINA
Connection Strength
0.033
Administration, Oral
  1. Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration. J Immunother Cancer. 2019 05 22; 7(1):136.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.